Abstract
Mycobacterium tuberculosis can be transmitted to patients (nosocomial or hospital-acquired infection) or to health care workers (occupational-acquisition) in health care facilities. Before the 1980s, reports of nosocomial M. tuberculosis transmission were rare (1–3). The lack of reports of nosocomial patient to patient M. tuberculosis transmission in health care facilities can be related to the fact that only approximately 5–10% of immunocompetent persons exposed to a patient with infectious tuberculosis (TB) will develop TB in their lifetime; if an immunocompetent patient were exposed to an infectious TB patient in the hospital, development of infection and then active disease would occur months to years after the hospital exposure and nosocomial acquisition would never be considered. Thus, unless there is a cluster of patients with newly diagnosed TB or patients infected with a M. tuberculosis strain with an unusual antimicrobial resistance pattern, nosocomial M. tuberculosis transmission might not be suspected or detected. Thus, although rarely reported, nosocomial transmission of M tuberculosis can occur and remain undetected. In contrast, occupational acquisition has been documented as a risk to health care workers in the United States since the early 1930s. From 1935 through 1939, Israel followed a cohort of 637 nursing students during their hospital training (4). At entry into the study, 360 (57%) nurses were tuberculin skin test (TST) negative and 277 (43%) were TST positive. All of the TST-negative nurses had TST conversions during their training. Of the 637 nursing students, 68 (11%) developed active tuberculosis. Subsequent studies in the 1930s and 1940s also documented high (79–85%) TST conversion rates among nurses (5,6). During the 1940s and 1950s, studies were conducted showing that the risk of active TB among medical school students was over three times higher than the general population (7). Risk factors for disease among the medical students included exposure to unrecognized TB patients, the men’s TB ward, or presence in the autopsy room.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Pope AS (1942) An outbreak of tuberculosis in infants due to hospital infection. J Pediatr 40:297–300.
Ehrenkranz JN, Kicklighter LJ (1972) Tuberculosis outbreak in a general hospital: Evidence for airborne spread of infection. Ann Intern Med 77:377–382.
Alpert ME, Levison ME (1965) An epidemic of tuberculosis in a medical school. New Engl J Med 272:718–721.
Israel HL, Hetherington HW, Ord JG (1941) A study of tuberculosis among students of nursing. J Am Med Assoc 117:839–844.
Brahdy L (1941) Immunity and positive tuberculin reaction. Am J Publ Health 31:1040–1043.
Badger TL, Ayvazian LF (1949) Tuberculosis in nurses: Clinical observations on its pathogenesis as seen in a fifteen year follow-up of 745 nurses. Am Rev Tuberc 60:305–327.
Abruzzi WA, Hummel RJ. Tuberculosis: Incidence among American medical students, prevention and the use of BCG. New Engl J Med 248:722–729.
Centers for Disease Control (1994) Expanded tuberculosis surveillance and tuberculosis morbidity—United States, 1993. Morbid Mortal Wkly Rep 43:361–366.
Barnes PF, Bloch AB, Davidson PT, Snider DE Jr (1991) Tuberculosis in patients with human immunodeficiency virus infection. New Engl J Med 324:1644–1650.
Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, and Freidland GH (1989) A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New Engl J Med 320:545–550.
Centers for Disease Control (1991) Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected person—Florida and New York, 1988–1991. Mortal Wkly Rep 40:585–591.
Dooley SW, Villarino ME, Lawrence M, Salinas L, Amil S, Rullan JV, Jarvis WR, Bloch AB, Cauthen GM (1992) Tuberculosis in a hospital unit for patients infected with the human immunodeficiency virus (HIV): Evidence of nosocomial transmission. J Am Med Assoc 267:2632–2634.
Di Perri G, Cruciani M, Danzi MC, Luzzati R, DeChecchi G, Malena M, Pizzighella S, Mazzi R, Solbiati M, and Concia E (1989) Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 2:1502–1504.
Edlin BR, Tokars JI, Grieco MH, Crawford JT, Williams J, Sordillo EM, Ong KR, Kilburn JO, Dooley SW, Castro KG, Jarvis WR, Holmberg SD (1992) An outbreak of multidrug-resistent tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome: Epidemiologic studies and restriction fragment length polymorphism analysis. New Engl J Med 326:1514–1522.
Tokars JI, Jarvis WR, Edlin BR, Dooley S, Grieco M, Gilligan ME, Schneider N, Montonez M, and Williams J (1992) Tuberculin skin testing of hospital employees during an outbreak of multidrug-resistant tuberculosis in human immunodeficiency virus (HIV)-infected patients. Infect control Hosp Epidemiol 13:509–510.
Beck-Sague CM, Dooley SW, Hutton MD, Otten J, Breeden A, Crawford JT, Pitchenik AE, Woodley C, Cauthen G, Jarvis WR (1992) Outbreak of multidrug-resistant tuberculosis among persons with HIV infection in an urban hospital: Transmission to staff and patients and control measures. J Am Med Assoc 268:1280–1286.
Fischl MA, Uttamchandani RB, Daikos GL, Poblete RB, Moreno JN, Reyes RR, Boota AM, Thompson LM, Cleary TJ and Lai S (1992) An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med 117:177–183.
Ikeda RM, Birkhead GS, DiFerdinando GT Jr, et al. (1995) Nosocomial tuberculosis: An outbreak of a strain resistant to seven drugs. Infect Control Hosp Epidemiol 16:152–159.
Pearson ML, Jereb JA, Frieden TR, Crawford JT, Davis B, Dooley SW, Jarvis WR (1992) Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: A risk to hospitalized patients and health-care workers. Ann Intern Med 117:191–196.
Valway SE, Greifinger RB, Papania M, Kilburn JO, Woodley C, Diferdinando GT, and Dooley SW (1994) Multidrug-resistant tuberculosis in the New York State prison system 1990–1991. J Infect Dis 170:151–156.
Coronado VG, Valway S, Finelli L, Dato V, Pineda MR, Yanaguchi E, Woodley CL, Crandell MS, and Jarvis, WR (1993) Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among intravenous drug users with human immunodeficiency virus infection (Abstract S50). Abstracts of the Third Annual Meeting of the Society for Hospital Epidemiology of America.
Coronado VG, Beck-Sague CM, Hutton MD, Davis BJ, Nicholas P, Villareal C, Woodley CL, Kilburn JO, Crawford JT, Frieden TR, Sinkowitz RL, Jarvis WR (1993) Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: Epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 168:1052–1055.
Jarvis WR (1993) Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Res Microbiol 144:117–122.
Coronado VG, Beck-Sague CM, Pearson ML, Dooley SW, Valway SE, Pineda MR and Jarvis WR (1993) Multidrug-resistant Mycobacterium tuberculosis among patients with HIV infection. Infect Dis Clin Pract 2:297–302.
Jereb JA, Klevens RM, Privett TD, Smith PJ, Crawford JT, Sharp VL, Davis BJ, Jarvis WR, and Dooley SW (1995) Tuberculosis in health care workers at a hospital with an outbreak of multidrug-resistant Mycobacterium tuberculosis. Arch Intern Med 155:854–859.
Cave MD, Eisenbach KD, McDernott PF, Bates JH, Crawford JT (1991) IS6110: Conservation of sequence in the Mycobacterium tuberculosis complex and its utilization in DNA finger printing. Molec Cell Probes 5:73–80.
Haas WH, Butler WR, Woodley CL, Crawford JT (1993) Mixed-linker polymerase chain reaction: A new method for rapid fingerprinting of the Mycobacterium tuberculosis complex. J Clin Microbiol 31:1293–1298.
Zaza S, Blumberg HM, Beck-Sague C, Parrish C, Pineda M, Woodley C, Crawford JT Jr, McGowan JE Jr, Jarvis WR (1995) Occupational Risk of Infection with Mycobacterium tuberculosis: Patients and healthcare workers as a source of infection. J Infect Dis 172:1542–1549.
Rudnick JR, Kroc K, Manangan L, Banerjee S, Pugliese G, Jarvis W (1992) How prepared are U.S. hospitals to control nosocomial transmission of tuberculosis? Presented at the First World Congress on Tuberculosis.
Fridkin SK, Manangan L, Bolyard E, SHEA, Jarvis WR (1995) SHEA-CDC TB survey, Part I: Status of TB infection control programs at member hospitals, 1989–1992. Infect Contr Hosp Epidemiol 16:129–134.
Fridkin SK, Manangan L, Bolyard E, SHEA, Jarvis WR (1992) SHEA-CDC survey-Part II: Efficacy of TB infection control programs at member hospitals, 1992. Infect Control Hosp Epidemiol 16:135–140.
Sinkowitz R, Fridkin S, Manangan L, Wenger P, APIC, Jarvis WR (1995) Status of tuberculosis infection control programs at U.S. hospitals, 1989–1992. Annual Meeting of the Association for Professional in Infection Control and Epidemiology.
Moran GJ, Fuchs MA, Jarvis WR, Talan DA (1995) Tuberculosis infection control practices at emergency departments in the United States, 1993–1994. J Am Med Assoc Ann Emerg Med 26:283–289.
Huebner RE, Good RC, Tokars JI (1993) Current practices in mycobacteriology: Results of a survey of state public health laboratories. J Clin Microbiol 31(4):771–775.
Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR, Good RC (1993) Guest Commentary. The Resurgence of tuberculosis: Is your laboratory ready? J Clin Microbiol 31(4):767–770.
Tokars JI, Rudnick JR, Kroc K, Manangan L, Pugliese G, Huebner RE, Chan J, and Jarvis WR (1996) U.S. hospital mycobacteriology laboratories: Status and comparison with state public health department laboratories. J Clin Microbiol 34(3):680–685.
CDC (1990) Guidelines for Preventing the Transmission of Tuberculosis in Tuberculosis in Health-Care Settings, with Special focus on HIV-Related Issues. Morbid Mortal Wkly Rep 39:No. RR-17.
CDC (1994) Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, 1994. Morbid Mortal Wkly Rep 43:No. RR1–13.
Maloney SA, Pearson ML, Gordon MT, DelCastillo R, Boyle JF, and Jarvis WR (1995) Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med 122:90–95.
Wenger PN, Otten J, Breeden A, Orfas D, Beck-Sague CM, and Jarvis WR (1995) Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HTV-infected patients. Lancet 345:235–240.
Stroud LA, Tokars JI, Grieco MH, Crawford JT, Culver DH, Edlin BR, Sordillo EM, Woodley CL, Gilligan ME, Schneider N, and Jarvis WR (1995) Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol 16:141–147.
Jarvis WR (1995) Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Am J Infect Control 23:146–151.
Jarvis WR, Bolyard EA, Bozzi CJ, Burwen DR, Dooley SW, Martin LS, Mullan RJ and Simone PM (1995) Respirators, recommendations, and regulations: The controversy surrounding protection of health care workers from tuberculosis. Ann Intern Med 122:142–146.
OSHA 29DFR-OSH (1972) 29 CFR 1910.134—occupational safety and health standards, personal protective equipment, respiratory protection. Code of Federal Regulation. Fed Reg 37:1910–1934.
Leidel NA, Mullan RJ (1992) NIOSH recommended guidelines for personal respiratory protection of workers in health-care facilities potentially exposed to tuberculosis. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health.
NIOSH 30CFR-NIOSH (1972) 30 CFR Part II—respiratory protective devices; tests for permissibility, fees. Code of Federal Regulations. Fed Reg 37:6243–6271.
Chen SK, Vesley D, Brosseau LM, and Vincent JH (1994) Evaluation of single-use masks and respirators for protection of health care workers against mycobacterial aerosols. Am J Infect Control 22:65–74.
US Department of Health and Human Services (1994) 42 CFR Part 84: Respiratory protective devices; proposed rule. Fed Reg 59:26849–26889.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Jarvis, W.R. (1998). Nosocomial Mycobacterium Tuberculosis Outbreaks: Risk Factors, Prevention Intervention Efficacy, and Guidelines. In: Gangadharam, P.R.J., Jenkins, P.A. (eds) Mycobacteria. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5987-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5987-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7743-6
Online ISBN: 978-1-4615-5987-0
eBook Packages: Springer Book Archive